1163 - Testing for gastric cancer for access to trastuzumab

Page last updated: 13 July 2016

Application Detail

Status

Closed

Description of Medical Service

In-situ hybridisation (ISH) for PBS listing of trastuzumab.

Description of Medical Condition

Previously untreated human epidermal growth factor receptor 2 (HER2) positive inoperable locally advanced or metastatic gastric or gastro-oesophageal cancer.

Reason for Application

New MBS item

Medical Service Type

Investigative

Previous Application Number

Not Applicable

Associated Documentation

Application Form

-

PICO Confirmation

14 - 15 September 2011
Final Decision Analytic Protocol (DAP) (PDF 542 KB)
Final Decision Analytic Protocol (DAP) (Word 1319 KB)

Assessment Report

-

Public Summary Document

Public Summary Document (PDF 697 KB)
Public Summary Document (Word 756 KB)

Meetings for this Application

PASC

7 July 2011

ESC

11 - 12 October 2012

MSAC

29 - 30 November 2012